[Latest] Global Naloxone Market Size/Share Worth USD 2,470.2 Million by 2032 at a 11% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
December 04, 2023 14:30 ET
|
Custom Market Insights
Austin, TX, USA, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Naloxone Market Size, Trends and Insights By Type (Injectable, Intranasal), By...
Webinar to Highlight Impact of Opioid Crisis on Vulnerable Populations
December 04, 2023 11:00 ET
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Dec. 04, 2023 (GLOBE NEWSWIRE) -- MILLBURN – State and local experts will continue the discussion of the opioid epidemic’s impact on vulnerable populations in the next webinar of the...
Opioid Drugs Market to Surpass $56.5 billion by 2030: Coherent Market Insights (CMI)
November 29, 2023 07:40 ET
|
CMI
Burlingame, Nov. 29, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global opioid drugs market was valued at US$ 45.0 Billion in 2023 and is forecast to reach a value of US$...
Webinar to Commemorate Statewide Knock Out Opioid Abuse Day
October 02, 2023 11:05 ET
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Oct. 02, 2023 (GLOBE NEWSWIRE) -- A national expert will outline the latest developments in the nationwide opioid epidemic in the next installment of the Knock Out Opioid Abuse Day...
Progress in the Battle Against Opioid Epidemic: New Jersey Records Decrease in Overdoses
September 25, 2023 11:31 ET
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Recently released provisional data by the Centers for Disease Control and Prevention (CDC) on opioid overdoses show New Jersey overdose numbers are...
Oral Thin Films Market to Exceed USD 7.1 Bn, Globally, by 2031, Registering at a CAGR of 9.3% | Exclusive Report by Transparency Market Research
August 15, 2023 05:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global oral thin films market is projected to flourish at a CAGR of 9.3% from 2022 to...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – RAD
March 26, 2023 16:44 ET
|
The Rosen Law Firm PA
NEW YORK, March 26, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018...
The Saving Our Children Campaign Launches in Southern California to Reduce Adolescent Drug Use
February 14, 2023 17:16 ET
|
Saving Our Children Campaign
LOS ANGELES, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The Saving Our Children Campaign launches its new initiative to use multimedia to educate parents and children about the dangers of drugs in Los...
Foundation for Opioid Response Efforts Announces Initiative to Help Schools Access Medicaid Funding for Substance Misuse Prevention Programs
October 31, 2022 14:22 ET
|
Foundation for Opioid Response Efforts
New York, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Medicaid funding is available to expand school-based substance misuse prevention programs, however many school districts have limited access to the...
Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
September 26, 2022 09:00 ET
|
Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OAK pain completed enrollment with last patient (n=120) dosedNo limiting toxicities have been encountered during the trial to date. Patients are now being monitored for...